{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:43Z","timestamp":1791314383590,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/nbt.1539","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T20:06:13Z","timestamp":1241381173000},"page":"478-484","source":"Crossref","is-referenced-by-count":216,"title":["Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs"],"prefix":"10.1038","volume":"27","author":[{"given":"Jiaxin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith T","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Gabillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Arar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Bezprozvanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,3]]},"reference":[{"key":"BFnbt1539_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr, H.T. & Zoghbi, H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575\u2013621 (2007).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnbt1539_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-2007-971172","volume":"27","author":"HL Paulson","year":"2007","unstructured":"Paulson, H.L. Dominantly inherited ataxias: Lessons learned from Machado-Joseph disease\/spinocerbeller ataxia type 3. Semin. Neurol. 27, 133\u2013142 (2007).","journal-title":"Semin. Neurol."},{"key":"BFnbt1539_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F.O. Huntington's disease. Lancet 369, 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"BFnbt1539_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.tibs.2006.06.009","volume":"31","author":"JF Gusella","year":"2006","unstructured":"Gusella, J.F. & MacDonald, M.E. Huntington's disease: seeing the pathogenic process through a genetic lens. Trends Biochem. Sci. 31, 533\u2013540 (2006).","journal-title":"Trends Biochem. Sci."},{"key":"BFnbt1539_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer, B. et al. A worldwide study of the Huntington's disease mutation: The sensitivity and specificity of measuring CAG repeats. N. Engl. J. Med. 330, 1401\u20131406 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnbt1539_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3565(24)38893-7","volume":"295","author":"RJ Boado","year":"2000","unstructured":"Boado, R.J., Kazantsev, A., Apostol, B.L., Thompson, L.M. & Pardridge, W.M. Antisense-mediated down-regulation of the mutant human huntingtin gene. J. Pharmacol. Exp. Ther. 295, 239\u2013243 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnbt1539_CR7","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820\u20135825 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1539_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.gt.3302664","volume":"13","author":"EM Denovan-Wright","year":"2006","unstructured":"Denovan-Wright, E.M. & Davidson, B.L. RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases. Gene Ther. 13, 525\u2013531 (2006).","journal-title":"Gene Ther."},{"key":"BFnbt1539_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","volume":"53","author":"Y-L Wang","year":"2005","unstructured":"Wang, Y.-L. et al. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA. Neurosci. Res. 53, 241\u2013249 (2005).","journal-title":"Neurosci. Res."},{"key":"BFnbt1539_CR10","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M. et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 104, 17204\u201317209 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1539_CR11","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1073\/pnas.1231012100","volume":"100","author":"VM Miller","year":"2003","unstructured":"Miller, V.M. et al. Allele-specific silencing of dominant disease genes. Proc. Natl. Acad. Sci. USA 100, 7195\u20137200 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1539_CR12","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","volume":"2","author":"DS Schwarz","year":"2006","unstructured":"Schwarz, D.S. et al. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet. 2, e140 (2006).","journal-title":"PLoS Genet."},{"key":"BFnbt1539_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/sj.gt.3302702","volume":"13","author":"E Rodriguez-Lebron","year":"2006","unstructured":"Rodriguez-Lebron, E. & Paulson, H.L. Allele-specific RNA interference for neurological disease. Gene Ther. 13, 576\u2013581 (2006).","journal-title":"Gene Ther."},{"key":"BFnbt1539_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/hum.2007.116","volume":"19","author":"PHJ van Bilsen","year":"2008","unstructured":"van Bilsen, P.H.J. et al. Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts. Hum. Gene Ther. 19, 710\u2013718 (2008).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt1539_CR15","doi-asserted-by":"publisher","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","volume":"3","author":"S Alves","year":"2008","unstructured":"Alves, S. et al. Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. PLoS One 3, e3341 (2008).","journal-title":"PLoS One"},{"key":"BFnbt1539_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y., Engelman, J. & Friedlander, R.M.J. Allele-specific silencing of mutant Huntington's disease gene. J. Neurochem. 108, 82\u201390 (2009).","journal-title":"J. Neurochem."},{"key":"BFnbt1539_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/npp.2008.115","volume":"34","author":"EB De Souza","year":"2009","unstructured":"De Souza, E.B., Cload, S.T., Pendergrast, P.S. & Sah, D.W. Novel therapeutic modalities to address nondrugable protein interaction targets. Neuropsychopharmacology 34, 142\u2013158 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"BFnbt1539_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir, J. et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811\u2013823 (1995).","journal-title":"Cell"},{"key":"BFnbt1539_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White, J.K. et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17, 404\u2013410 (1997).","journal-title":"Nat. Genet."},{"key":"BFnbt1539_CR20","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1093\/nar\/gkg766","volume":"31","author":"K Sobczak","year":"2003","unstructured":"Sobczak, K., de Mezer, M., Michlewski, G., Krol, J. & Krzyzosiak, W.J. RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res. 31, 5469\u20135482 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt1539_CR21","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.1021\/ja051102y","volume":"127","author":"VL Marin","year":"2005","unstructured":"Marin, V.L. & Armitage, B.A. RNA guanine quadruplex invasion by complementary and homologous PNA probes. J. Am. Chem. Soc. 127, 8032\u20138033 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnbt1539_CR22","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.1021\/bi700230a","volume":"46","author":"J Hu","year":"2007","unstructured":"Hu, J. & Corey, D.R. Inhibiting gene expression with peptide nucleic acid (PNA)-peptide conjugates that target chromosomal DNA. Biochemistry 46, 7581\u20137589 (2007).","journal-title":"Biochemistry"},{"key":"BFnbt1539_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow, E.J. et al. Selective striatal neuronal loss in a YAC128 mouse model for Huntington disease. Hum. Mol. Genet. 12, 1555\u20131567 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnbt1539_CR24","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"T-S Tang","year":"2005","unstructured":"Tang, T.-S. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. USA 102, 2602\u20132607 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1539_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/nar\/24.3.494","volume":"24","author":"H Knudsen","year":"1996","unstructured":"Knudsen, H. & Nielsen, P.E. Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res. 24, 494\u2013500 (1996).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt1539_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nchembio724","volume":"1","author":"BA Janowski","year":"2005","unstructured":"Janowski, B.A. et al. Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nat. Chem. Biol. 1, 210\u2013215 (2005).","journal-title":"Nat. Chem. Biol."},{"key":"BFnbt1539_CR27","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1021\/ja00141a038","volume":"117","author":"DR Corey","year":"1995","unstructured":"Corey, D.R. 48,000-fold acceleration of hybridization of chemically modified oligonucleotides to duplex DNA. J. Am. Chem. Soc. 117, 9373\u20139374 (1995).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnbt1539_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1039\/9781847558275-00103","volume-title":"Therapeutic Oligonucleotides","author":"T Koch,","year":"2008","unstructured":"Koch, T. et al. Locked nucleic acid: Properties and therapeutic aspects. in Therapeutic Oligonucleotides (ed. Kurreck, J.) 103\u2013141, (RSC Biomolecular Sciences, Royal Society of Chemistry, Cambridge, UK, 2008)."},{"key":"BFnbt1539_CR29","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","volume":"30","author":"J Kurreck","year":"2002","unstructured":"Kurreck, J., Wyszko, E., Gillen, C. & Erdmann, V.A. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30, 1911\u20131918 (2002).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt1539_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot, D., Manoharan, M., Koteliansky, V. & Sah, D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2, 711\u2013719 (2006).","journal-title":"Nat. Chem. Biol."},{"key":"BFnbt1539_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/hmg\/4.5.807","volume":"4","author":"H Maruyama","year":"1995","unstructured":"Maruyama, H. et al. Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum. Mol. Genet. 4, 807\u2013812 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"BFnbt1539_CR32","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1172\/JCI25424","volume":"116","author":"RA Smith","year":"2006","unstructured":"Smith, R.A. et al. Antisense oligonucleotide therapy for neurodegenerative disease. J. Clin. Invest. 116, 2290\u20132296 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1539_CR33","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","volume":"97","author":"C Wahlestedt","year":"2000","unstructured":"Wahlestedt, C. et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. USA 97, 5633\u20135638 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1539_CR34","doi-asserted-by":"publisher","first-page":"8994","DOI":"10.1158\/0008-5472.CAN-07-1045","volume":"67","author":"MF Corsten","year":"2007","unstructured":"Corsten, M.F. et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 67, 8994\u20139000 (2007).","journal-title":"Cancer Res."},{"key":"BFnbt1539_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/nchembio0107-8","volume":"3","author":"DR Corey","year":"2007","unstructured":"Corey, D.R. RNAi learns from antisense. Nat. Chem. Biol. 3, 8\u201311 (2007).","journal-title":"Nat. Chem. Biol."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.1539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1539","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T07:33:12Z","timestamp":1739086392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.1539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFnbt1539"],"URL":"https:\/\/doi.org\/10.1038\/nbt.1539","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}